top of page

Insights and News Curated for Life Science Experts by Life Science Experts....

Go back to...
JMG Logo transparent.png
Executive Spotlights

Teva names Richard Francis as CEO

  • Nov 22, 2023
  • 1 min read

Tel Aviv, Israel, November 21, 2023 (Reuters) -- Teva Pharmaceutical (TEVA.TA) has named Richard Francis, former executive at Novartis (NOVN.S) and Biogen (BIIB.O), as the successor to CEO Kare Schultz, set to retire later this year. Currently leading gene therapy firm Purespring Therapeutics and biopharma company Forcefield Therapeutics, Francis will assume the position of Teva's president, starting Jan. 1, 2023.


Read full article here.

 
 
 

Recent Posts

See All
Qlaris Bio Appoints Fred Guerard as CEO

Dedham, MA, March 1, 2026 (Business Wire) -- Qlaris Bio has appointed Fred Guerard, Pharm.D., as president and chief executive officer, effective March 1, 2026, and he will also join the company’s b

 
 
 

Comments


Life Science Headlines
bottom of page